Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization

Poxvirus prime-protein boost used in the RV144 trial remains the only immunization strategy shown to elicit a modest level of protection against HIV-1 acquisition in humans. Although neutralizing antibodies (NAb) were generated, they were against sensitive viruses, not the more resistant “tier 2” is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Townsley, Samantha, Mohamed, Zeinab, Guo, Wenjin, McKenna, Jennifer, Cleveland, Brad, LaBranche, Celia, Beaumont, David, Shen, Xiaoying, Yates, Nicole L., Pinter, Abraham, Tomaras, Georgia D., Ferrari, Guido, Montefiori, David C., Hu, Shiu-Lok
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021413/
https://ncbi.nlm.nih.gov/pubmed/27440894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00853-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados